| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |